These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 36357934)
1. The Women's Health Initiative cancer survivorship clinic incorporating electronic patient-reported outcomes: a study protocol for the Linking You to Support and Advice (LYSA) randomized controlled trial. Kearns N; Raigal-Aran L; O'Connell K; Davis A; Bermingham K; O'Reilly S; Collins DC; Corrigan M; Coulter J; Cleary V; Cushen S; Flavin A; Byrne F; O'Grady A; O'Neill D; Murphy A; Dahly D; Palmer B; Connolly RM; Hegarty J Pilot Feasibility Stud; 2022 Nov; 8(1):238. PubMed ID: 36357934 [TBL] [Abstract][Full Text] [Related]
2. App-Controlled Treatment Monitoring and Support for Patients With Head and Neck Cancer Undergoing Radiotherapy: Results From a Prospective Randomized Controlled Trial. Sprave T; Pfaffenlehner M; Stoian R; Christofi E; Rühle A; Zöller D; Fabian A; Fahrner H; Binder H; Schäfer H; Gkika E; Grosu AL; Heinemann F; Nicolay NH J Med Internet Res; 2023 Oct; 25():e46189. PubMed ID: 37856185 [TBL] [Abstract][Full Text] [Related]
3. A head and neck cancer intervention for use in survivorship clinics: a protocol for a feasibility study. Salz T; McCabe MS; Oeffinger KC; Corcoran S; Vickers AJ; Salner AL; Dornelas E; Schnall R; Raghunathan NJ; Fortier E; Baxi SS Pilot Feasibility Stud; 2016; 2():23. PubMed ID: 27965842 [TBL] [Abstract][Full Text] [Related]
4. Implementation of patient-reported outcomes for symptom management in oncology practice through the SIMPRO research consortium: a protocol for a pragmatic type II hybrid effectiveness-implementation multi-center cluster-randomized stepped wedge trial. Hassett MJ; Wong S; Osarogiagbon RU; Bian J; Dizon DS; Jenkins HH; Uno H; Cronin C; Schrag D; Trials; 2022 Jun; 23(1):506. PubMed ID: 35710449 [TBL] [Abstract][Full Text] [Related]
5. Optimizing veteran-centered prostate cancer survivorship care: study protocol for a randomized controlled trial. Skolarus TA; Metreger T; Hwang S; Kim HM; Grubb RL; Gingrich JR; Hawley ST Trials; 2017 Apr; 18(1):181. PubMed ID: 28420419 [TBL] [Abstract][Full Text] [Related]
6. Design and evaluation of a digital health intervention with proactive follow-up by nurses to improve healthcare and outcomes for patients with breast cancer in Mexico: protocol for a randomised clinical trial. Contreras Sánchez SE; Doubova SV; Grajales Álvarez R; Dip Borunda AK; Martínez Pineda WJ; Nuñez Cerrillo JG; Silva Bravo F; Zalapa Velázquez R; Gutiérrez De la Barrera M; Leslie HH BMJ Open; 2023 Nov; 13(11):e077322. PubMed ID: 37931967 [TBL] [Abstract][Full Text] [Related]
7. Rationale and design of extended cancer education for longer term survivors (EXCELS): a randomized control trial of 'high touch' vs. 'high tech' cancer survivorship self-management tools in primary care. Davis SN; O'Malley DM; Bator A; Ohman-Strickland P; Clemow L; Ferrante JM; Crabtree BF; Miller SM; Findley P; Hudson SV BMC Cancer; 2019 Apr; 19(1):340. PubMed ID: 30971205 [TBL] [Abstract][Full Text] [Related]
8. Developing a real-time electronic symptom monitoring system for patients after discharge following cancer-related surgery. Avery KNL; Richards HS; Portal A; Reed T; Harding R; Carter R; Bamforth L; Absolom K; O'Connell Francischetto E; Velikova G; Blazeby JM BMC Cancer; 2019 May; 19(1):463. PubMed ID: 31101017 [TBL] [Abstract][Full Text] [Related]
9. CovEMERALD: Assessing the feasibility and preliminary effectiveness of remotely delivered Eye Movement Desensitisation and Reprocessing following Covid-19 related critical illness: A structured summary of a study protocol for a randomised controlled trial. Bates A; Rushbrook S; Shapiro E; Grocott M; Cusack R Trials; 2020 Nov; 21(1):929. PubMed ID: 33203440 [TBL] [Abstract][Full Text] [Related]
10. Correction: The Women's Health Initiative cancer survivorship clinic incorporating electronic patient-reported outcomes: a study protocol for the Linking You to Support and Advice (LYSA) randomized controlled trial. Kearns N; Raigal-Aran L; O'Connell K; Davis A; Bermingham K; O'Reilly S; Collins DC; Corrigan M; Coulter J; Cleary V; Cushen S; Flavin A; Byrne F; O'Grady A; O'Neill D; Murphy A; Dahly D; Palmer B; Connolly RM; Hegarty J Pilot Feasibility Stud; 2022 Dec; 8(1):255. PubMed ID: 36510292 [No Abstract] [Full Text] [Related]
11. A Narrative Review on the Collection and Use of Electronic Patient-Reported Outcomes in Cancer Survivorship Care with Emphasis on Symptom Monitoring. van den Hurk CJG; Mols F; Eicher M; Chan RJ; Becker A; Geleijnse G; Walraven I; Coolbrandt A; Lustberg M; Velikova G; Charalambous A; Koczwara B; Howell D; Basch EM; van de Poll-Franse LV Curr Oncol; 2022 Jun; 29(6):4370-4385. PubMed ID: 35735458 [TBL] [Abstract][Full Text] [Related]
12. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study. Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796 [TBL] [Abstract][Full Text] [Related]
13. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial. Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739 [TBL] [Abstract][Full Text] [Related]
14. Implementing Symptom Management Follow-up Using an Electronic Patient-Reported Outcome Platform in Outpatients With Advanced Cancer: Longitudinal Single-Center Prospective Study. Tang L; He Y; Pang Y; Su Z; Li J; Zhang Y; Wang X; Han X; Wang Y; Li Z; He S; Song L; Zhou Y; Wang B; Li X JMIR Form Res; 2022 May; 6(5):e21458. PubMed ID: 35536608 [TBL] [Abstract][Full Text] [Related]
15. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related]
16. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial. Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924 [TBL] [Abstract][Full Text] [Related]
17. Partnering with general practitioners to optimize survivorship for patients with lymphoma: a phase II randomized controlled trial (the GOSPEL I trial). Chan RJ; Buhagiar S; Teleni L; Simonsen C; Turner J; Rawson C; Hart NH; Jones L; Gordon L; Joseph R; Agbejule OA; Henderson F; Rhee J; Ryan M; Carrington C; Mapp S Trials; 2021 Jan; 22(1):12. PubMed ID: 33407797 [TBL] [Abstract][Full Text] [Related]
18. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
19. Home-based multidimensional survivorship programmes for breast cancer survivors. Cheng KKF; Lim YTE; Koh ZM; Tam WWS Cochrane Database Syst Rev; 2017 Aug; 8(8):CD011152. PubMed ID: 28836379 [TBL] [Abstract][Full Text] [Related]